134 related articles for article (PubMed ID: 33290794)
21. Bio-orthogonal click-targeting nanocomposites for chemo-photothermal synergistic therapy in breast cancer.
Qiao J; Tian F; Deng Y; Shang Y; Chen S; Chang E; Yao J
Theranostics; 2020; 10(12):5305-5321. PubMed ID: 32373214
[TBL] [Abstract][Full Text] [Related]
22. Molecular imaging based on metabolic glycoengineering and bioorthogonal click chemistry.
Yoon HY; Koo H; Kim K; Kwon IC
Biomaterials; 2017 Jul; 132():28-36. PubMed ID: 28399460
[TBL] [Abstract][Full Text] [Related]
23. Near-infrared imaging of adoptive immune cell therapy in breast cancer model using cell membrane labeling.
Youniss FM; Sundaresan G; Graham LJ; Wang L; Berry CR; Dewkar GK; Jose P; Bear HD; Zweit J
PLoS One; 2014; 9(10):e109162. PubMed ID: 25334026
[TBL] [Abstract][Full Text] [Related]
24. Near-infrared fluorescence imaging of CD13 receptor expression using a novel Cy5.5-labeled dimeric NGR peptide.
Li G; Xing Y; Wang J; Conti PS; Chen K
Amino Acids; 2014 Jun; 46(6):1547-56. PubMed ID: 24652439
[TBL] [Abstract][Full Text] [Related]
25. Cytosolic protein delivery via metabolic glycoengineering and bioorthogonal click reactions.
Zhao Z; Zhang Z; Duan S; Liu X; Zhou R; Hou M; Sang Y; Zhu R; Yin L
Biomater Sci; 2021 Jul; 9(13):4639-4647. PubMed ID: 34036971
[TBL] [Abstract][Full Text] [Related]
26. Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma.
Sun L; Guo H; Jiang R; Lu L; Liu T; He X
Tumour Biol; 2016 Jan; 37(1):799-806. PubMed ID: 26250457
[TBL] [Abstract][Full Text] [Related]
27. Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
Kawaoka T; Oka M; Takashima M; Ueno T; Yamamoto K; Yahara N; Yoshino S; Hazama S
Oncol Rep; 2008 Jul; 20(1):155-63. PubMed ID: 18575732
[TBL] [Abstract][Full Text] [Related]
28. Intercellular delivery of bioorthogonal chemical receptors for enhanced tumor targeting and penetration.
Tu Y; Dong Y; Wang K; Shen S; Yuan Y; Wang J
Biomaterials; 2020 Nov; 259():120298. PubMed ID: 32827798
[TBL] [Abstract][Full Text] [Related]
29. Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice.
Verra NC; Jorritsma A; Weijer K; Ruizendaal JJ; Voordouw A; Weder P; Hooijberg E; Schumacher TN; Haanen JB; Spits H; Luiten RM
Cancer Res; 2004 Mar; 64(6):2153-61. PubMed ID: 15026357
[TBL] [Abstract][Full Text] [Related]
30. Facile metabolic glycan labeling strategy for exosome tracking.
Lee TS; Kim Y; Zhang W; Song IH; Tung CH
Biochim Biophys Acta Gen Subj; 2018 May; 1862(5):1091-1100. PubMed ID: 29410228
[TBL] [Abstract][Full Text] [Related]
31. Artificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes.
Sun L; Guo H; Jiang R; Lu L; Liu T; Zhang Z; He X
Oncotarget; 2016 Apr; 7(14):17579-90. PubMed ID: 27007051
[TBL] [Abstract][Full Text] [Related]
32. Cathepsin B-Specific Metabolic Precursor for In Vivo Tumor-Specific Fluorescence Imaging.
Shim MK; Yoon HY; Ryu JH; Koo H; Lee S; Park JH; Kim JH; Lee S; Pomper MG; Kwon IC; Kim K
Angew Chem Int Ed Engl; 2016 Nov; 55(47):14698-14703. PubMed ID: 27762044
[TBL] [Abstract][Full Text] [Related]
33. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control.
Vianello F; Papeta N; Chen T; Kraft P; White N; Hart WK; Kircher MF; Swart E; Rhee S; Palù G; Irimia D; Toner M; Weissleder R; Poznansky MC
J Immunol; 2006 Mar; 176(5):2902-14. PubMed ID: 16493048
[TBL] [Abstract][Full Text] [Related]
34. In Situ Bioorthogonal Metabolic Labeling for Fluorescence Imaging of Virus Infection In Vivo.
Pan H; Li WJ; Yao XJ; Wu YY; Liu LL; He HM; Zhang RL; Ma YF; Cai LT
Small; 2017 May; 13(17):. PubMed ID: 28218446
[TBL] [Abstract][Full Text] [Related]
35. Nanobody-Engineered Natural Killer Cell Conjugates for Solid Tumor Adoptive Immunotherapy.
Gong L; Li Y; Cui K; Chen Y; Hong H; Li J; Li D; Yin Y; Wu Z; Huang Z
Small; 2021 Nov; 17(45):e2103463. PubMed ID: 34761524
[TBL] [Abstract][Full Text] [Related]
36. Adenoviral gene transfer of interleukin 12 into tumors synergizes with adoptive T cell therapy both at the induction and effector level.
Mazzolini G; Qian C; Narvaiza I; Barajas M; Borrás-Cuesta F; Xie X; Duarte M; Melero I; Prieto J
Hum Gene Ther; 2000 Jan; 11(1):113-25. PubMed ID: 10646644
[TBL] [Abstract][Full Text] [Related]
37. Generation of populations of antigen-specific cytotoxic T cells using DCs transfected with DNA construct encoding HER2/neu tumor antigen epitopes.
Kuznetsova M; Lopatnikova J; Khantakova J; Maksyutov R; Maksyutov A; Sennikov S
BMC Immunol; 2017 Jun; 18(1):31. PubMed ID: 28633645
[TBL] [Abstract][Full Text] [Related]
38. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.
Alexander-Miller MA; Leggatt GR; Berzofsky JA
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4102-7. PubMed ID: 8633023
[TBL] [Abstract][Full Text] [Related]
39. In vivo distribution and antitumor effect of infused immune cells in a gastric cancer model.
Du X; Jin R; Ning N; Li L; Wang Q; Liang W; Liu J; Xu Y
Oncol Rep; 2012 Nov; 28(5):1743-9. PubMed ID: 22948809
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
